Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
132.55
+42.17 (46.66%)
At close: Jun 22, 2026, 4:00 PM EDT
132.62
+0.07 (0.05%)
After-hours: Jun 22, 2026, 7:52 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $9.93 billion as of June 22, 2026. Its market cap has increased by 352.06% in one year.
Market Cap
9.93B
Enterprise Value
8.68B
1-Year Change
352.06%
Ranking
Category
Stock Price
$132.55
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $9.93B, an increase of 1,128.15%. That is a compound annual growth rate of 134.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 9.93B | 95.02% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 11.82B |
| Arrowhead Pharmaceuticals | 11.55B |
| Summit Therapeutics | 11.08B |
| BioMarin Pharmaceutical | 10.80B |
| Cytokinetics | 10.75B |
| Krystal Biotech | 10.12B |
| Nuvalent | 9.75B |
| Spyre Therapeutics | 8.71B |